GLYNORAP-M1 is specialized diabetes pharmaceutical combining glimepiride (sulfonylurea stimulating insulin secretion) with sustained-release metformin (biguanide enhancing insulin sensitivity) for dual-mechanism type 2 diabetes control addressing both insulin production and utilization pathways. This synergistic combination provides superior glycemic control compared to monotherapy through complementary mechanisms, with typical HbA1c reductions of 1.5-2% supporting target achievement and preventing diabetes progression. This makes GLYNORAP-M1 an ideal choice for healthcare providers seeking an effective and convenient solution for managing type 2 diabetes in a single, easy-to-take tablet form.
GLYNORAP-M1: Glimepiride + Metformin for Diabetes Management
Category: Tablets
Packaging: 10x10 Blister
Composition: Glimepiride IP 1mg + Metformin Hydrochloride IP 500mg (Sustained Release)
Therapeutic Class: Antidiabetic
Strength: 1mg + 500mg SR per tablet
MRP: ₹799.00
SCHEDULE H PRESCRIPTION DRUG - WARNING:To be sold by retail on the prescription of a Registered Medical Practitioner only.
Request Info Introduction
Uses & Indications
- Type 2 diabetes management
- Blood glucose control
- Diabetes prevention in prediabetic patients
- Combination therapy for better glycemic control
- Weight management in diabetics
Contraindications
- Type 1 diabetes
- Kidney disease
- Heart failure
Side Effects
The side effects listed below may occur with the use of this medication. However, not all individuals experience these effects.
- Hypoglycemia (low blood sugar)
- Gastrointestinal disturbances
- Headache
- Dizziness
- Vitamin B12 deficiency (long-term)
Precautions
- Monitor blood glucose regularly
- Take with meals
- Avoid alcohol
Safety Advice & Precautions
- Take with meals to minimize GI upset
- Monitor blood glucose regularly
- Avoid alcohol consumption
- Inform doctor of kidney disease
- Regular liver and kidney function tests required
- Report severe dizziness or confusion
Storage Conditions
Store at temperature not exceeding 25°C. Keep away from moisture.
Shelf Life & Expiry
24 months
Frequently Asked Questions
Should GLYNORAP-M1 be taken with meals or on an empty stomach?
Take with or immediately after meals
What are the signs of low blood sugar to monitor while taking GLYNORAP-M1?
Trembling, sweating, dizziness, confusion
Can I combine GLYNORAP-M1 with other diabetes medications?
May combine with others, doctor decides
How frequently should I monitor my health levels while on GLYNORAP-M1?
Check as advised, typically 2-4 times weekly
Medical Disclaimer
This product information is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a healthcare professional before starting any new medication or changing your dosage. Rapid Pharmaceuticals is not responsible for any adverse effects resulting from the misuse of this medication.
